
Vivo Capital
58 portfolio companies · 8 on the map · $860.2M raised · 8 cities
Portfolio map
8 Vivo Capital portfolio companies on the map.
Portfolio companies

Compass Pathways
London
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Mental Health Care$771.2MEst. 2016
SCIENTIA VASCULAR
West Valley City
Scientia Vascular is a medical device company that provides endovascular devices that assist in complex and minimally invasive procedures.
Medical Equipment Manufacturing$89MEst. 2007
Ossium Health
San Francisco
Ossium applies bioengineering to improve health, vitality, and longevity, aiming to extend human life and well-being across all life stages.
Biotechnology$15KEst. 2016Sera Prognostics
Salt Lake City
Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.
Biotechnology ResearchPublicEst. 2008- KA
Kadmon, a Sanofi Company
New York
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Biotechnology ResearchPublic 
ADARx Pharmaceuticals
San Diego
ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene
BiotechnologyEst. 2019
Tarsus Pharmaceuticals
Irvine
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Pharmaceutical ManufacturingPublicEst. 2017Hiring fastImpel Pharmaceuticals
Keller
Keller-based · pharmaceutical manufacturing.
Pharmaceutical ManufacturingEst. 2008
More portfolio companies
48 more Vivo Capital investments we track beyond the map — 58 tracked in total.
Ajax TherapeuticsCambridge · Series C
CAMP4 TherapeuticsCambridge · Post-IPO Equity
BlossomHill TherapeuticsSan Diego · Series B
Terns PharmaceuticalsFoster City · Series C
Compass TherapeuticsBoston · Post-IPO Equity
Design TherapeuticsSolana Beach · Series B
EpiBiologicsSan Mateo · Series B
Bristol-Myers SquibbNew York · Post-IPO Equity
Akari TherapeuticsLondon · Post-IPO Equity
Revolution MedicinesRedwood City · Series C
Zai LabShanghai · Series C
NeocisMiami · Series D
Aligos TherapeuticsSan Francisco · Series B
PatientPopSanta Monica · Series C
ORIC PharmaceuticalsSouth San Francisco · Post-IPO Equity
Cidara TherapeuticsSan Diego · Post-IPO Equity
Ascendis PharmaPalo Alto · Series D
AttralusSan Francisco · Series B
KALA BIOWaltham · Series C
Bonum TherapeuticsSeattle · Series A
SurrozenSouth San Francisco · Post-IPO Equity
PulmocideLondon · Series C
Abeona TherapeuticsNew York · Post-IPO Equity
Cerebral TherapeuticsAurora · Series C
ALX OncologySan Francisco · Series C
INBRACEIrvine · Series D
Avadel PharmaceuticalsDublin · Post-IPO Equity
Pasithea TherapeuticsMiami Beach · Post-IPO Equity
InnocareChangping · Post-IPO Equity
Revance TherapeuticsNewark · Series D
AerobiotixMiamisburg · Venture
AmyrisEmeryville · Post-IPO Equity
Outpost MedicineIndianapolis · Series A
Delcath SystemsNew York · Post-IPO Equity
Sierra OncologySan Mateo · Series D
Regulus TherapeuticsSan Diego · Post-IPO Equity
Sinovac BiotechBeijing · Post-IPO Equity
IGM BiosciencesMountain View · Series C
TricidaMenlo Park · Series D
NeurogastrxWoburn · Series B
ESSA PharmaVancouver · Post-IPO Equity
CAPNIAPalo Alto · Series B
Sagent PharmaceuticalsSchaumburg · Series A
Angiotech PharmaceuticalsVancouver · Venture
Synapse BiomedicalOberlin · Venture
Copernicus TherapeuticsCleveland · Venture
CotherixSan Francisco · Series C
Transcept PharmaceuticalsRichmond · Series D
Portfolio map
8 Vivo Capital portfolio companies on the map.